Literature DB >> 6342225

Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts.

W W Hancock, N M Thomson, R C Atkins.   

Abstract

Monoclonal antibodies and a four-layer immunoperoxidase technique were used to analyze and quantitate the various infiltrating cell types found in percutaneous renal biopsies of 25 patients undergoing acute renal allograft rejection. Cell markers included monoclonal antibodies to the human leukocyte-common antigen (PHM 1), mononuclear phagocytes (PHM 2, FMC 32), T cells and T cell subsets (OKT 3, OKT 4, and OKT 8), B cells (7.2), polymorphs (FMC 10, FMC 13), and plasma cells (OKT 10). The proportion of labelled interstitial cells was expressed as a percentage of the total number of infiltrating leukocytes identified with PHM 1, and correlated with the histologically graded intensity of rejection. In mild rejection 32% of the infiltrating cells were T lymphocytes, of which 90% were OKT-8-positive cytotoxic-suppressor cells, and 52% were macrophages. Similarly, in moderate rejection T cells composed 42% of the infiltrate (with 67% of T cells expressing OKT 8 antigen), and macrophages formed 38% of the total cells. By contrast, in severe rejection, the T cell component was decreased to 15% of the cells, of which 78% were OKT-8-positive; these were preponderantly macrophages (60%) and polymorphs (22%). These studies demonstrate that cytotoxic-suppressor T cells and macrophages are the major cells mediating acute interstitial graft rejection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342225     DOI: 10.1097/00007890-198305000-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  39 in total

Review 1.  Tubular and interstitial factors in the progression of glomerulonephritis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1992-05       Impact factor: 3.714

Review 2.  The innate immune system in allograft rejection and tolerance.

Authors:  David F LaRosa; Adeeb H Rahman; Laurence A Turka
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

3.  Monocyte infiltration and kidney allograft dysfunction during acute rejection.

Authors:  R Girlanda; D E Kleiner; Z Duan; E A S Ford; E C Wright; R B Mannon; A D Kirk
Journal:  Am J Transplant       Date:  2008-03       Impact factor: 8.086

Review 4.  Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation.

Authors:  Verena Bröcker; Michael Mengel
Journal:  Pediatr Nephrol       Date:  2013-10-19       Impact factor: 3.714

5.  Simultaneous detection of B-cells and T-cells by a double immunohistochemical technique using immunogold-silver staining and the avidin-biotin-peroxidase complex method.

Authors:  H Sako; Y Nakane; K Okino; K Nishihara; M Kodama; M Kawata; H Yamada
Journal:  Histochemistry       Date:  1986

Review 6.  Effector mechanisms of rejection.

Authors:  Aurélie Moreau; Emilie Varey; Ignacio Anegon; Maria-Cristina Cuturi
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

7.  Histological signs of immune reactions against allogeneic solid fetal neural grafts in the mouse cerebellum depend on the MHC locus.

Authors:  I Date; K Kawamura; H Nakashima
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

8.  Relationships among injury, fibrosis, and time in human kidney transplants.

Authors:  Jeffery M Venner; Konrad S Famulski; Jeff Reeve; Jessica Chang; Philip F Halloran
Journal:  JCI Insight       Date:  2016-01-21

9.  18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis.

Authors:  Matthias Nahrendorf; Edmund Keliher; Peter Panizzi; Hanwen Zhang; Sheena Hembrador; Jose-Luiz Figueiredo; Elena Aikawa; Kimberly Kelly; Peter Libby; Ralph Weissleder
Journal:  JACC Cardiovasc Imaging       Date:  2009-10

Review 10.  The divergent roles of macrophages in solid organ transplantation.

Authors:  Sahar Salehi; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.